Ayşegül Atmaca

6PUBLICATIONS
39CO-AUTHORS
Environmental biogeochemistryDigital electronic devicesPredictive and prognostic markersCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 05, 2026
Endocrine-disrupting chemicals in metabolic bone diseases, including osteoporosis.

Betül Gündüz, Elif Kiliç Kan, Ayşegül Atmaca

|Jan 17, 2025
Evaluation of ACE I/D and ATIR A1166C variants in patients with diabetes mellitus with and without peripheral neuropathy in Turkish patients.

Payam Amiri Dashatan, Huseyin Soylu, Mehmet Elbistan

|Oct 18, 2024
Prognostic factors for aggressiveness in subcentimeter papillary thyroid carcinoma: impact of tumor size and lymph node metastases.

Yusuf Kayhan, Leyla Azizova, Merve Yılmaz

|Jul 24, 2024
Granulation Patterns of Functional Corticotroph Tumors Correlate with Tumor Size, Proliferative Activity, T2 Intensity-to-White Matter Ratio, and Postsurgical Early Biochemical Remission.

Elif Tutku Durmuş, Mehmet Kefeli, Ozgur Mete

|Feb 04, 2022
Higher rate of COVID-19 mortality in patients with type 1 than type 2 diabetes: a nationwide study.

Ibrahim Demirci, Cem Haymana, Ilker Tasci

|Aug 17, 2021
No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study.

A Atmaca, I Demirci, C Haymana

Pageof 1

Frequent Collaborators

2 joint publications

Elif Kılıç Kan

2 joint publications

Ramis Çolak

2 joint publications

Mehmet Kefeli

1 joint publications

Betül Gündüz